ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,905.11
      0.15%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Supernus Pharmaceuticals Inc (SUPN)

      7. Supernus Pharmaceuticals Inc (SUPN) Financials

      Supernus Pharmaceuticals Inc

      Supernus Pharmaceuticals Inc (SUPN)

      NASDAQ
      30.75
      0.07
      (0.23%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      30.75
      0.03
      (0.10%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Supernus Pharmaceuticals Inc Financial Summary

      The current SUPN market cap is 1.69B. The company's latest EPS is USD 0.0239 and P/E is 1285.36.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 167.84M155.41M134.77M154.34M164.52M
      Operating Income 32.44M5.18M-17.59M8.14M-996k
      Net Income 25.48M16.95M-831k-15.98M1.18M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 392.76M520.4M586.31M667.75M609.04M
      Operating Income 148.57M173.7M86.03M46.12M-5.27M
      Net Income 113.06M126.95M53.42M60.71M1.32M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.7B1.79B1.29B1.29B1.28B
      Total Liabilities 816.3M879.66M373.19M372.97M356.16M
      Total Equity 886.2M912.15M919.91M912.19M921.52M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.16B1.5B1.69B1.7B1.28B
      Total Liabilities 564.85M759.24M873.3M816.3M356.16M
      Total Equity 595.43M744.86M815.85M886.2M921.52M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 116.83M49.13M30.25M66.13M111.09M
      Investing -216.66M239.78M300.08M334.71M268.73M
      Financing -10.48M80.17M-398.74M-398.97M-397.88M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 143.13M138.4M127.13M116.83M111.09M
      Investing -157.92M-34.7M-81.91M-216.66M268.73M
      Financing 3.93M3.56M-130.42M-10.48M-397.88M

      Stats and Ratios

      Market Cap 1.69B
      Price to Earnings Ratio 1285.36
      Price to Sales Ratio 2.77
      Price to Cash Ratio 22.5
      Price to Book Ratio 1.83
      Dividend Yield -

      Share Statistics

      Shares Outstanding 54.97M
      Average Volume (1 week) 583.32k
      Average Volume (1 Month) 536.84k
      52 Week Change 1.85%
      52 Week High 35.44
      52 Week Low 21.99
      Spread (Intraday) 2.99 (9.33%)

      Company Info

      Company Name Supernus Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.supernus.com
      Industry pharmaceutical preparations (2834)